BE900650A - Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine. - Google Patents
Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine.Info
- Publication number
- BE900650A BE900650A BE0/213703A BE213703A BE900650A BE 900650 A BE900650 A BE 900650A BE 0/213703 A BE0/213703 A BE 0/213703A BE 213703 A BE213703 A BE 213703A BE 900650 A BE900650 A BE 900650A
- Authority
- BE
- Belgium
- Prior art keywords
- composition
- extract
- detoxified endotoxin
- refined detoxified
- microorganism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composition pharmaceutique constituée d'un excipient, d'un extrait soluble dans la pyridine, purifié, d'un microorganisme et d'une endotoxine détoxifiée raffinée. La composition en question convient au traitement de tumeurs cancéreuses. On injecte la composition par la voie parentérale ou directement dans la tumeur.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/535,037 US4663306A (en) | 1983-09-23 | 1983-09-23 | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BE900650A true BE900650A (fr) | 1985-03-21 |
Family
ID=24132594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/213703A BE900650A (fr) | 1983-09-23 | 1984-09-21 | Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4663306A (fr) |
JP (1) | JPS60120817A (fr) |
KR (1) | KR870000843B1 (fr) |
AT (1) | AT385659B (fr) |
AU (1) | AU566234B2 (fr) |
BE (1) | BE900650A (fr) |
CA (1) | CA1244765A (fr) |
CH (1) | CH664897A5 (fr) |
DE (1) | DE3434766A1 (fr) |
DK (1) | DK446684A (fr) |
ES (1) | ES8608872A1 (fr) |
FI (1) | FI843716L (fr) |
FR (1) | FR2552326B1 (fr) |
GB (1) | GB2149301B (fr) |
HU (1) | HU192585B (fr) |
IL (1) | IL73034A (fr) |
IN (1) | IN157240B (fr) |
IT (1) | IT1179444B (fr) |
NL (1) | NL8402902A (fr) |
NO (1) | NO843776L (fr) |
NZ (1) | NZ209635A (fr) |
SE (1) | SE8404707L (fr) |
ZA (1) | ZA847405B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4844894A (en) * | 1984-07-12 | 1989-07-04 | Ribi Immunochem Research Inc. | Method of inhibiting the onset of septicemia and endotoxemia |
US4806352A (en) * | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
US4929604A (en) * | 1986-05-28 | 1990-05-29 | Board Of Regents, The University Of Texas System | Lipopolysaccharides of reduced toxicity and the production thereof |
AU7488794A (en) * | 1993-08-27 | 1995-03-21 | Vetrepharm, Inc. | Composition and method for stimulation of reproductive performance |
BE1007823A3 (fr) * | 1993-12-10 | 1995-10-31 | Anda Biolog Sa | Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer. |
US6090385A (en) * | 1993-12-10 | 2000-07-18 | Maes; Hubert | Method of treating cancer |
US5976580A (en) | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
DE19710255A1 (de) * | 1997-03-13 | 1998-09-17 | Henkel Ecolab Gmbh & Co Ohg | Verwendung einer Lösung zur Desaktivierung von Endotoxinen |
IL134371A0 (en) | 1997-08-05 | 2001-04-30 | Bioniche Life Sciences Inc | Composition and method for regulating cell proliferation and cell death |
US6019985A (en) * | 1998-02-27 | 2000-02-01 | Munova Corporation | Immunostimulation methods for providing disease protection in poultry |
JP4447779B2 (ja) | 1998-07-16 | 2010-04-07 | 市郎 東 | 細菌の菌体成分を有効成分とする癌免疫療法用製剤 |
MXPA02005842A (es) * | 1999-12-13 | 2003-10-14 | Bioniche Life Sciences Inc | Oligonucleotidos sinteticos terapeuticamente utiles. |
WO2001047561A1 (fr) * | 1999-12-28 | 2001-07-05 | Bioniche Life Sciences Inc. | L'acide hyaluronique dans le traitement du cancer |
NZ523535A (en) * | 2000-07-11 | 2004-12-24 | Bayer Ag | Use of strains of the Parapoxvirus ovis against organ fibroses |
BR0215643A (pt) * | 2002-03-05 | 2004-12-21 | Cell Medicine Inc | Adjuvante imunológico de tecido solidificado |
WO2004012751A1 (fr) * | 2002-08-02 | 2004-02-12 | Sumitomo Pharmaceuticals Company, Limited | Preparation d'un compose bacterien de squelette de paroi cellulaire |
FR2848223B1 (fr) * | 2002-12-09 | 2005-02-25 | Centre Nat Rech Scient | Nouveau procede d'isolement des endotoxines. |
WO2005023277A1 (fr) * | 2003-09-05 | 2005-03-17 | Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. | Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale |
CA2564180A1 (fr) * | 2004-04-22 | 2005-11-03 | Dainippon Sumitomo Pharma Co., Ltd. | Preparation pharmaceutique contenant un composant du squelette de la paroi de cellules bacteriennes |
WO2014172637A1 (fr) | 2013-04-18 | 2014-10-23 | Immune Design Corp. | Monothérapie par gla pour une utilisation dans le traitement du cancer |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
WO2015195845A1 (fr) | 2014-06-17 | 2015-12-23 | Xycrobe Therapeutics, Inc. | Bactéries génétiquement modifiées et procédés de modification génétique de bactéries |
US11504404B2 (en) | 2016-02-24 | 2022-11-22 | Crown Laboratories, Inc. | Skin probiotic formulation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7308450A (fr) * | 1972-06-20 | 1973-12-27 | ||
FR2269962B1 (fr) * | 1974-05-06 | 1978-02-03 | Anvar | |
JPS58874B2 (ja) * | 1979-08-30 | 1983-01-08 | 株式会社 目黒研究所 | 糖蛋白wenac及びその製造法 |
US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
CA1209504A (fr) * | 1982-06-30 | 1986-08-12 | John L. Cantrell | Extrait de microorganisme soluble dans la pyridine |
CA1206415A (fr) * | 1982-06-30 | 1986-06-24 | John L. Cantrell | Extrait de pyridine soluble provenant de microorganismes |
CA1206416A (fr) * | 1982-06-30 | 1986-06-24 | John L. Cantrell | Extrait de pyridine soluble provenant de microorganismes |
-
1983
- 1983-09-23 US US06/535,037 patent/US4663306A/en not_active Expired - Lifetime
-
1984
- 1984-09-19 DK DK446684A patent/DK446684A/da not_active Application Discontinuation
- 1984-09-20 NO NO843776A patent/NO843776L/no unknown
- 1984-09-20 SE SE8404707A patent/SE8404707L/xx not_active Application Discontinuation
- 1984-09-20 ZA ZA847405A patent/ZA847405B/xx unknown
- 1984-09-21 CH CH4544/84A patent/CH664897A5/de not_active IP Right Cessation
- 1984-09-21 NL NL8402902A patent/NL8402902A/nl not_active Application Discontinuation
- 1984-09-21 BE BE0/213703A patent/BE900650A/fr not_active IP Right Cessation
- 1984-09-21 CA CA000463800A patent/CA1244765A/fr not_active Expired
- 1984-09-21 DE DE19843434766 patent/DE3434766A1/de active Granted
- 1984-09-21 FI FI843716A patent/FI843716L/fi not_active Application Discontinuation
- 1984-09-21 FR FR8414533A patent/FR2552326B1/fr not_active Expired
- 1984-09-21 ES ES536167A patent/ES8608872A1/es not_active Expired
- 1984-09-21 GB GB08423993A patent/GB2149301B/en not_active Expired
- 1984-09-21 NZ NZ209635A patent/NZ209635A/xx unknown
- 1984-09-21 HU HU843585A patent/HU192585B/hu unknown
- 1984-09-21 AU AU33400/84A patent/AU566234B2/en not_active Ceased
- 1984-09-22 KR KR1019840005821A patent/KR870000843B1/ko active
- 1984-09-23 IL IL73034A patent/IL73034A/xx unknown
- 1984-09-24 AT AT0302384A patent/AT385659B/de not_active IP Right Cessation
- 1984-09-24 IT IT48894/84A patent/IT1179444B/it active
- 1984-09-25 JP JP59198764A patent/JPS60120817A/ja active Granted
- 1984-09-25 IN IN677/CAL/84A patent/IN157240B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE900650A (fr) | Composition d'endotoxine detoxifiee raffinee et d'un extrait d'un microorganisme soluble dans la pyridine. | |
FR2527443B1 (fr) | Composition contenant de l'endotoxine raffinee et medicament la contenant | |
ES8704005A1 (es) | Un metodo para evaluar la probabilidad de malignidad celular en una muestra biologica de un haspedante humano. | |
AU6760987A (en) | Method of treating alzheimer's disease | |
LU91498I2 (fr) | Etanercept et ses dérivés pharmaceutiquement acceptables. | |
NO852872L (no) | Fremgangsmaate for fremstilling av nye tetrapyrroler. | |
ES8205231A1 (es) | Procedimiento para preparar complejos de platino (iv)-diami-na | |
OA07103A (fr) | Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant. | |
ES2010561A6 (es) | Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina. | |
ATE232394T1 (de) | Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs | |
ES2004245A6 (es) | Un procedimiento para la produccion de un anticuerpo monoclonal | |
GB2217330B (en) | Lipolytic material associated with cachexia inducing tumours, preparations,production and uses thereof. | |
HUT61202A (en) | Process for producing pharmaceutical compositions neutralizing procoagulant activity caused by tumour cells | |
DZ1390A1 (fr) | Procédé de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïque et de médicaments les contenant. | |
DE69720783D1 (de) | Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie | |
ES2068587T3 (es) | Medicamentos tumorales sustituidos con polieter. | |
ES8506806A1 (es) | Procedimiento para la preparacion de una proteina hipocolesterolemicamente activa | |
EP0096007A3 (en) | Pharmaceutical preparation containing (+)-cyanidan-3-ol derivatives, the use thereof, novel substituted (+)-cyanidan-3-ol derivatives, and processes for producing them | |
DE69026371D1 (de) | Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren | |
WO1992018536A3 (fr) | Procede de detection et de localisation de tissus comprenant des recepteurs de neurokinine 1 | |
EP0295559A3 (en) | Pharmaceutical composition for the treatment of tumors | |
EP0254593A3 (fr) | Préparation et applications d'interféron gamma | |
FR2631829B1 (fr) | Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant | |
IE871358L (en) | Interferon for carcinoma | |
ES8300780A1 (es) | Procedimiento para preparar oxido de bis(cloroetil-butilestano) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: RIBI IMMUNOCHEM RESEARCH INC. Effective date: 19900930 |